OMGstudy (@OMGstudy1) header
OMGstudy (@OMGstudy1) profile picture

International prevalence investigation targeting assessment and management of Peripheral Intravenous Cannula across 50 countries. Tweets by @pcarriv #FOAMva

Australia
Joined April 2013
Photo by OMGstudy (@OMGstudy1)Photo by OMGstudy (@OMGstudy1)Photo by OMGstudy (@OMGstudy1)Photo by OMGstudy (@OMGstudy1)Photo by OMGstudy (@OMGstudy1)Photo by OMGstudy (@OMGstudy1)Photo by OMGstudy (@OMGstudy1)Photo by OMGstudy (@OMGstudy1)Photo by OMGstudy (@OMGstudy1)Photo by OMGstudy (@OMGstudy1)
Collaboration is key when talking IV! The #HMS team had an amazing visit with the @AVATAR_grp from Australia, focusing on our #PICC initiative. HMS is lucky to collaborate with such an inspiring group! #creatingchange
6
1
18
Literally OMG! Australia we need to do better than this! @OMGstudy1 @graybarruel @AVATAR_grp @acn_tweet #NNF2018
6
10
We need a national response to these findings
Our main study findings have featured in Australian media #FOAMva #FOAMed
1
4
OMGstudy retweeted
Liz Simcock on patient involvement #ppi in a bundle of care for patients with vascular access 👍 #wocova18 now ⁦@OMGstudy1⁩ lead Dr. Alexandrou on pre-insertion and insertion bundles
1
7
22
Idle PIVs can lead to healthcare associated infections called (wait for it)... PLABSI Internationallly, idle PIVs are being targeted in efforts to reduce hospital onset Staph aureus bacteremia Great initial data on global PIV use in new @JHospMedicine work nitter.cf/claire_avatar/status/1…
We have to talk about PIVCs - Global OMG Study shows many areas for improvement Use of Short Peripheral Intravenous Catheters: Characteristics, Management, and Outcomes Worldwide journalofhospitalmedicine.co…
1
4
10
Great work by the @OMGstudy1 team @AVATAR_grp #OnlyOneIV nitter.cf/avatar_grp/status/1002… – at Brisbane, Queensland
>40,000 PIVCs, 416 hospitals, 51 countries, plenty of improvements to be made. Let's get to work! journalofhospitalmedicine.co… @AlexandrouE @OMGstudy1 @graybarruel @Claire_AVATAR @lauramalberto @Lin_Frances1 @pcarriv @NiallHiggins5 @StevenAFrost
3
6
A massive survey of >40,000 PIVCs in 51 countries. The current state of clinical management of IV lines seems sadly pretty poor. Huge potential for improved practice! Great work by @Claire_AVATAR and team @AVATAR_grp journalofhospitalmedicine.co…
2
3
11
Does anyone out there in the #FOAMed world have any ideas preventing pts leaving with IV cannulas in situ? @mmbangor @stemlyns @ketaminh
11
3
4
Do u know ur REAL PIVC failure rate is? @OMGstudy1 @AVATAR_grp research. Vasopressors NOT appropriate by several standards & guidelines #
2
2
@graybarruel presenting the vital work @OMGstudy1 - always keen to hear this! #AVAS17 @AVATAR_grp @AVASociety @pcarriv @Claire_AVATAR – at Perth, Western Australia
3
2
Replying to @OMGstudy1
@OMGstudy1 data on #phlebitis rates Vs Cannulation ed - 7% with, 13% without - clear assoc'n of ed &⬇️phlebitis #AVAS17 @AVATAR_grp – at Perth, Western Australia
Boost your track record. VA writing workshop at AVAS SM 10-12 May 2017 eecw.eventsair.com/avasasm20… @pcarriv @AVATAR_grp @PaedAVAS #FOAMed – at Brisbane, Queensland
3
1
VA ultrasound workshop at AVAS SM 10-12 May 2017 Book now! eecw.eventsair.com/avasasm20… @pcarriv @AVATAR_grp @PaedAVAS #FOAMed – at Brisbane, Queensland
2
1
The Australian Vascular Access Society’s (AVAS) 2017 Scientific Meeting coming up soon. Register NOW at ow.ly/Z9PM30aKkxr @pcarriv
3
3
The countdown is on! Still time to register! ln.is/avas.org.au/Mu5GG @AVASociety @pcarriv @S2Keogh
3
3
Good news for any late comers - the presentations wiil be available for viewing @ @AVATAR_GRP website in near future avatargroup.org.au nitter.cf/pcarriv/status/8385552…
1
5
4
Hola! Proud to speak today on @OMGstudy1 and clinically indicated PIV replacement policy in Colombia. Great people, great coffee!
Final week to get abstracts in and share your IV stories and studies avasasm.org.au/call-for-abst… @AVATAR_grp @pcarriv – at Brisbane, Queensland
4
7